Oral administration of Bifidobacterium longum ameliorates influenza virus infection in mice

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 8, 2011, Pages 1352-1355

  Iwabuchi, Noriyuki ^a   Xiao, Jin Zhong ^a   Yaeshima, Tomoko ^a   Iwatsuki, Keiji ^a  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

BB536; Bifidobacterium; Infection; Influenza virus; Probiotics

Indexed keywords

BB 536; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 6; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BIFIDOBACTERIUM LONGUM; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; INFLUENZA; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; VIRUS INHIBITION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIFIDOBACTERIUM; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PROBIOTICS; WEIGHT LOSS;

EID: 80051481351     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.1352     Document Type: Article

References (21)

1. Tamura S., Kurata T., Jpn. J. Infect. Dis., 57, 236-247 (2004).
2. Ichinohe T., Iwasaki A., Hasegawa H., Expert Rev. Vaccines, 7, 1435-1445 (2008).
3. McGill J., Heusel J. W., Legge K. L., J. Leukoc. Biol., 86, 803-812 (2009).
4. Myśliwska J., Myśliwski A., Romanowski P., Bigda J., Sosnowska D., Foerster J., Gerontology, 38, 41-49 (1992).
5. Tregoning J. S., Schwarze J., Clin. Microbiol. Rev., 23, 74-98 (2010).
6. WAO/WHO, "Guidelines for the Evaluation of Probiotics in Food, Reprot of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food" 〈http://www.who.int/foodsafety/fs- management/en/probiotic-guidelines.pdf〉, London, ON, Canada, 2002.
7. Yasui H., Kiyoshima J., Hori T., Shida K., Clin. Diagn. Lab. Immunol., 6, 186-192 (1999).
8. Hori T., Kiyoshima J., Shida K., Yasui H., Clin. Diagn. Lab. Immunol., 9, 105-108 (2002).
9. Yasui H., Kiyoshima J., Hori T., Clin. Diagn. Lab. Immunol., 11, 675-679 (2004).
10. Maeda N., Nakamura R., Hirose Y., Murosaki S., Yamamoto Y., Kase T., Yoshikai Y., Int. Immunopharmacol., 9, 1122-1125 (2009).
11. Kawase M., He F., Kubota A., Harata G., Hiramatsu M., Lett. Appl. Microbiol., 51, 6-10 (2010).
12. Kobayashi N., Saito T., Uematsu T., Kishi K., Toba M., Kohda N., Suzuki T., Int. Immunopharmacol., 11, 199-203 (2011).
13. Leyer G. J., Li S., Mubasher M. E., Reifer C., Ouwehand A. C., Pediatrics, 124, e172-e179 (2009).
14. Xiao J. Z., "Hanbook of Probiotics and Prebiotics," 2nd ed., Chap. 6.14, ed. by Lee K. L., Salminen S., John Wiley & Sons, Inc., New Jersey, 2009, pp. 488-491.
15. Iwabuchi N., Hiruta N., Shimizu K., Yaeshima T., Iwatsuki K., Yasui H., Milk Science, 58, 129-133 (2009).
16. Namba K., Hatano M., Yaeshima T., Takase M., Suzuki K., Biosci. Biotechnol. Biochem., 74, 939-945 (2010).
17. Toapanta F. R., Ross T. M., Respir. Res., 10, 112 (2009).
18. Xiao J. Z., Kondo S., Yanagisawa N., Takahashi N., Odamaki T., Iwabuchi N., Iwatsuki K., Kokubo S., Togashi H., Enomoto K., Enomoto T., J. Investig. Allergol. Clin. Immunol., 16, 86-93 (2006).
19. Xiao J. Z., Kondo S., Yanagisawa N., Takahashi N., Odamaki T., Iwabuchi N., Miyaji K., Iwatsuki K., Togashi H., Enomoto K., Enomoto T., Clin. Exp. Allergy, 36, 1425-1435 (2006).
20. Culley F. J., Immunology, 128, 151-163 (2009).
21. Kozak W., Poli V., Soszynski D., Conn C. A., Leon L. R., Kluger M. J., Am. J. Physiol., 272, R621-R630 (1997).